Alto Neuroscience Inc.
(ANRO)
undefined
undefined%
At close: undefined
3.93
4.66%
After-hours Dec 16, 2024, 04:37 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 |
Net Income | -36.30M | -27.71M | -9.19M |
Depreciation & Amortization | 373.00K | 342.00K | 145.00K |
Stock-Based Compensation | 2.89M | 1.76M | 227.00K |
Other Working Capital | -391.00K | 2.42M | 255.00K |
Other Non-Cash Items | 291.00K | 915.00K | 1.47M |
Deferred Income Tax | - | - | - |
Change in Working Capital | -698.00K | 4.58M | -572.00K |
Operating Cash Flow | -33.45M | -20.39M | -9.26M |
Capital Expenditures | -470.00K | -732.00K | -680.00K |
Acquisitions | - | - | - |
Purchase of Investments | - | - | - |
Sales Maturities Of Investments | - | - | - |
Other Investing Acitivies | - | - | - |
Investing Cash Flow | -470.00K | -732.00K | -680.00K |
Debt Repayment | - | 9.82M | - |
Common Stock Repurchased | - | - | - |
Dividend Paid | - | - | - |
Other Financial Acitivies | 67.95M | 33.92M | 31.68M |
Financial Cash Flow | 68.13M | 43.79M | 31.69M |
Net Cash Flow | 34.20M | 22.64M | 21.70M |
Free Cash Flow | -33.92M | -21.13M | -9.94M |